Precise ERBB2 copy number assessment in breast cancer by means of molecular inversion probe array analysis

HER2/ERBB2 amplification/overexpression determines the eligibility of breast cancer patients to HER2-targeted therapy. This study evaluates the agreement between ERBB2 copy number assessment by fluorescence in situ hybridization, a standard method recommended by the American Society of Clinical Onco...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Oncotarget
Main Authors: Christgen, Matthias, van Luttikhuizen, Jana L., Raap, Mieke, Braubach, Peter, Schmidt, Lars, Jonigk, Danny, Feuerhake, Friedrich, Lehmann, Ulrich, Schlegelberger, Brigitte, Kreipe, Hans H., Steinemann, Doris
Formato: Artigo
Idioma:Inglês
Publicado em: Impact Journals LLC 2016
Assuntos:
Research Paper
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5347728/
https://ncbi.nlm.nih.gov/pubmed/27716627
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.12421
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados